Skip to content

Buyer landscape

Likely buyers · Pharma in United Kingdom.

Prepared 2026-08-28 with GP Intel · deterministic scoring, published weights: gp-intel.com/methodology/league-tables

How companies like this sold · 199 verified exits: 26% to sponsors, 65% to corporates and platforms, 7% via IPO, 2% other routes. Route shift since 2020: sponsors 19% (was 41%), corporates and platforms 74% (was 47%), IPO 4% (was 11%).

The list: 25 Tier 1 · 0 Tier 2 of 120 matched buyers, including 5 geographic expansion candidates without a local platform yet. A first round of the Tier 1 names plus the expansion buyers covers the demonstrated demand.

Financial buyers · 25

Tier 1 · Very High · score 70+

1. Inflexion SponsorVery High85

10 platform investments in Healthcare · 55 in United Kingdom · 27 deals 2024–26

AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M

4 platform investments since the 2026 vintage · mid-deployment vs its usual 6 per fund.

Bought Primed from Paragon Partners, 2026 · MedTech, Germany

2. Inflexion (Partnership Capital III) SponsorVery High83

9 platform investments in Healthcare · 52 in United Kingdom · 25 deals 2024–26

AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M

Accelerating: 15 deals in the last 2 years vs 5.0/yr before.

Backed Primed, 2026 · MedTech, Germany

3. ARCHIMED and Institut Mérieux SponsorVery High83

54 platform investments in Healthcare · 3 in United Kingdom · 19 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

4. NORD Holding SponsorVery High83

15 platform investments in Healthcare · 3 in United Kingdom · 15 deals 2024–26

AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying

Accelerating: 13 deals in the last 2 years vs 2.5/yr before.

Backed NEC MED PHARMA GmbH, 2016 · Pharma, Germany

5. ArchiMed SponsorVery High82

56 platform investments in Healthcare · 4 in United Kingdom · 18 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

6. Archimedes Partners SponsorVery High82

53 platform investments in Healthcare · 3 in United Kingdom · 21 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

7. ArchiMed and Tethys Invest SponsorVery High82

54 platform investments in Healthcare · 3 in United Kingdom · 18 deals 2024–26

AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M

18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.

Backed IRAB, 2026 · Pharma, Spain

8. Bridgepoint SponsorVery High81

34 platform investments in Healthcare · 87 in United Kingdom · 43 deals 2024–26

AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M

4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.

Bought PharmaZell from Maxburg Capital Partners, 2020 · Pharma, Germany

9. Bridgepoint Development Capital SponsorVery High81

31 platform investments in Healthcare · 81 in United Kingdom · 36 deals 2024–26

AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M

4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.

Backed PharmaZell, 2020 · Pharma, Germany

10. Bridgepoint (52.5% majority stake) SponsorVery High81

30 platform investments in Healthcare · 80 in United Kingdom · 36 deals 2024–26

AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M

4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.

Backed PharmaZell, 2020 · Pharma, Germany

11. Bridgepoint BE VII + General Atlantic SponsorVery High81

30 platform investments in Healthcare · 80 in United Kingdom · 37 deals 2024–26

AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M

4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.

Backed PharmaZell, 2020 · Pharma, Germany

12. Bridgepoint Capital SponsorVery High81

31 platform investments in Healthcare · 81 in United Kingdom · 36 deals 2024–26

AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M

4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.

Backed PharmaZell, 2020 · Pharma, Germany

13. Bridgepoint Capital Developpement SponsorVery High81

30 platform investments in Healthcare · 80 in United Kingdom · 36 deals 2024–26

AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M

4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.

Backed PharmaZell, 2020 · Pharma, Germany

14. Bridgepoint Development Capital (with Paluel-Marmont Capital & LT Capital) SponsorVery High81

30 platform investments in Healthcare · 80 in United Kingdom · 36 deals 2024–26

AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M

4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.

Backed PharmaZell, 2020 · Pharma, Germany

15. Bpifrance Investissement SponsorVery High80

10 platform investments in Healthcare · 35 deals 2024–26

AUM €57.3B · Bpifrance Amorçage Industriel · 2023 vintage · deploying · check €1-8M

Accelerating: 30 deals in the last 2 years vs 4.5/yr before.

Backed Biogaran, 2026 · Pharma, France

16. Merieux Equity Partners / Vitruvian Partners SponsorVery High80

57 platform investments in Healthcare · 2 in United Kingdom · 6 deals 2024–26

AUM €1.6B · Mérieux Participations 5 · 2026 vintage · deploying · check €7-50M

2 platform investments since the 2026 vintage · early in deployment vs its usual 8 per fund.

Backed CEVA Santé Animale, 2025 · Pharma, France

17. IK Partners SponsorVery High79

34 platform investments in Healthcare · 19 in United Kingdom · 52 deals 2024–26

AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M

18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.

Backed Ceva Santé Animale, 2003 · Pharma, France

18. BC Partners SponsorVery High78

19 platform investments in Healthcare · 12 in United Kingdom · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

19. Charterhouse Capital Partners SponsorVery High78

11 platform investments in Healthcare · 18 in United Kingdom · 10 deals 2024–26

AUM €7.0B · Charterhouse Capital Partners XI · 2023 vintage · deploying · check €28-210M

10 platform investments since the 2023 vintage · mid-deployment vs its usual 14 per fund.

Backed Labomar, 2023 · Pharma, Italy

20. BC Partners / PSP Investments / Ontario Teachers SponsorVery High78

13 platform investments in Healthcare · 8 in United Kingdom · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

21. BC Partners + Intermediate Capital Group SponsorVery High78

13 platform investments in Healthcare · 8 in United Kingdom · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

22. BC Partners and AXA Private Equity SponsorVery High78

14 platform investments in Healthcare · 8 in United Kingdom · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

23. BC Partners Fund XI and CPP Investments SponsorVery High78

13 platform investments in Healthcare · 8 in United Kingdom · 5 deals 2024–26

AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M

5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.

Backed InfoRLife, 2026 · Pharma, Switzerland

24. NORD Holding / Pinova Capital SponsorVery High78

12 platform investments in Healthcare · 2 in United Kingdom · 12 deals 2024–26

AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying

Accelerating: 10 deals in the last 2 years vs 2.5/yr before.

Backed NEC MED PHARMA GmbH, 2016 · Pharma, Germany

25. EQT SponsorVery High77

50 platform investments in Healthcare · 16 in United Kingdom · 51 deals 2024–26

AUM €291.0B · EQT X · 2023 vintage · deploying · check €440M-3.3B

53 platform investments since the 2023 vintage · largely deployed vs its usual 11 per fund.

Backed Dechra Pharmaceuticals, 2024 · Pharma, UK

Scores and facts derive from verified deal records only; sample floors and thresholds are published on the methodology page. Figures marked with a tilde are bands, not disclosures.